{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:21:44Z","timestamp":1775064104968,"version":"3.50.1"},"reference-count":61,"publisher":"Informa UK Limited","issue":"12","funder":[{"name":"European Development Regional Fund"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,8,13]]},"DOI":"10.1080\/14656566.2021.1939680","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T07:52:02Z","timestamp":1623484322000},"page":"1521-1531","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["An overview of cilastatin + imipenem + relebactam as a therapeutic option for hospital-acquired and ventilator-associated bacterial pneumonia: evidence to date"],"prefix":"10.1080","volume":"22","author":[{"given":"J\u00falia","family":"Sellar\u00e8s-Nadal","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Study of Infectious Diseases (REIPI), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sime\u00f3n","family":"Eremiev","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Burgos","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Study of HIV (RIS), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1189-2361","authenticated-orcid":false,"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Study of Infectious Diseases (REIPI), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-644ST"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1602581"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-001-1143-z"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.16226"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1559820"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001091"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2007.10.020"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353"},{"key":"cit0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/656407","volume":"51","author":"Jones RN","year":"2010","journal-title":"Clin Infect Dis"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.174"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir202"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.073262-0"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1177\/0897190014546836"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00064-16"},{"key":"cit0015","unstructured":"FDA. Recarbrio Label FDA. 2019;1\u201317."},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz149"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01443-17"},{"key":"cit0018","volume-title":"Presented at: IDWeek","year":"2017"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-020-0710-9"},{"issue":"1","key":"cit0020","first-page":"1","volume":"63","author":"Sabet M","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3063-z"},{"key":"cit0022","unstructured":"Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens - Full Text View - ClinicalTrials.gov [Internet]. [cited 2021 Mar 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03032380"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz415.2487"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1739269"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30403-7"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03590-3"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02036-13"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.Supplement_3.S389"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767070-00006"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00296-11"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00174-18"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.12.101"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl354"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2378"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12010"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.11.025"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.03.022"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0851-9"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00642-17"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00672-19"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03517-y"},{"issue":"10","key":"cit0042","first-page":"2286","volume":"68","author":"Livermore DM","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00533-18"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S224228"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00997-19"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00830-15"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001142"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01125-16"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01992-17"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12462"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01411-17"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1563071"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00115-20"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz530"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa803"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku111"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00280-18"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00633-16"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx139"},{"key":"cit0060","unstructured":"FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia | FDA [Internet] [cited 2021 Mar 15]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-antibiotic-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated"},{"key":"cit0061","unstructured":"Recarbrio | European Medicines Agency [Internet]. [cited] 2021 Mar 15]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/recarbrio"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1939680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T13:40:13Z","timestamp":1631022013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1939680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,8,13]]}},"alternative-id":["10.1080\/14656566.2021.1939680"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1939680","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}